NCT07710495
- Conditions
- Behavior, Deconditioning, Motor Activity, +1 more
- Locations
-
- University of Surrey Guildford, Surrey, United Kingdom
Clinical trial condition
Pancreas Adenocarcinoma (MSI-H)
Explore clinical trials studying Pancreas Adenocarcinoma (MSI-H). Study availability and eligibility vary by location and protocol.
4 public trials
2 recruiting studies
Pancreas Adenocarcinoma (MSI-H) trial results
Recruiting
A Beta-only IL-2 ImmunoTherapY Study
NCT05086692
- Conditions
- Acral Melanoma, Adenocarcinoma, Adenoma, +120 more
- Locations
-
- Sharp Memorial Hospital San Diego, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- Providence Saint John's Health Center Santa Monica, California, United States
- Boca Raton Regional Hospital Boca Raton, Florida, United States
Not Yet Recruiting
A Trial Using Transcriptomic Signatures to Personalize Neoadjuvant Chemotherapy (NAC) for Patients With Resectable Borderline Pancreatic Adenocarcinoma (PDAC)
NCT07592819
- Conditions
- Pancreas Adenocarcinoma (MSI-H), Pancreatic Cancer Resectable
- Locations
-
Not specified
NCT07274657
- Conditions
- Pancreas Adenocarcinoma (MSI-H), Pancreatic Neuroendocrine Tumors (pNET)
- Locations
-
- Hôpital Privé Jean Mermoz Lyon, France